国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pongo pygmaeus Taste receptor type 2 member 1 (TAS2R1), partial CSB-YP723762EXP1
CSB-EP723762EXP1
CSB-BP723762EXP1
CSB-MP723762EXP1
CSB-EP723762EXP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pan troglodytes Taste receptor type 2 member 1 (TAS2R1), partial CSB-YP723763EQV1
CSB-EP723763EQV1
CSB-BP723763EQV1
CSB-MP723763EQV1
CSB-EP723763EQV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupaniopsis anacardioides Maturase K (matK), partial CSB-YP723764CGAO
CSB-EP723764CGAO
CSB-BP723764CGAO
CSB-MP723764CGAO
CSB-EP723764CGAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Insulin receptor-related protein (Insrr), partial CSB-YP723765RA
CSB-EP723765RA
CSB-BP723765RA
CSB-MP723765RA
CSB-EP723765RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Trifunctional purine biosynthetic protein adenosine-3 (Gart), partial CSB-YP723766MO
CSB-EP723766MO
CSB-BP723766MO
CSB-MP723766MO
CSB-EP723766MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fowl adenovirus A serotype 1 Uncharacterized protein ORF12 (12) CSB-YP723767FCL
CSB-EP723767FCL
CSB-BP723767FCL
CSB-MP723767FCL
CSB-EP723767FCL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fowl adenovirus A serotype 1 Minor capsid protein 6 (PVI) CSB-YP723768FCL
CSB-EP723768FCL
CSB-BP723768FCL
CSB-MP723768FCL
CSB-EP723768FCL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fowl adenovirus A serotype 1 Uncharacterized protein ORF19 (19) CSB-YP723769FCL
CSB-EP723769FCL
CSB-BP723769FCL
CSB-MP723769FCL
CSB-EP723769FCL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arctic squirrel hepatitis virus s External core antigen (C) CSB-YP723770AEAP
CSB-EP723770AEAP
CSB-BP723770AEAP
CSB-MP723770AEAP
CSB-EP723770AEAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African horse sickness virus 2 Non-structural protein NS3 (S10) CSB-YP723771AEAQ
CSB-EP723771AEAQ
CSB-BP723771AEAQ
CSB-MP723771AEAQ
CSB-EP723771AEAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Apple stem pitting virus Movement and silencing protein TGBp1 (ORF2) CSB-YP723772AEAA
CSB-EP723772AEAA
CSB-BP723772AEAA
CSB-MP723772AEAA
CSB-EP723772AEAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant White clover cryptic virus 1 Capsid protein CSB-YP723773WAAD
CSB-EP723773WAAD
CSB-BP723773WAAD
CSB-MP723773WAAD
CSB-EP723773WAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chrotomys sibuyanensis Cytochrome b (MT-CYB), partial CSB-YP723774CGAP
CSB-EP723774CGAP
CSB-BP723774CGAP
CSB-MP723774CGAP
CSB-EP723774CGAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hylobates lar Glutamate dehydrogenase 2, mitochondrial (GLUD2), partial CSB-YP723775HXW
CSB-EP723775HXW
CSB-BP723775HXW
CSB-MP723775HXW
CSB-EP723775HXW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Myotis lesueuri Cytochrome b (MT-CYB), partial CSB-YP723776MEAX
CSB-EP723776MEAX
CSB-BP723776MEAX
CSB-MP723776MEAX
CSB-EP723776MEAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Subtilisin-like protease 6 (SUB6) CSB-YP723777DON
CSB-EP723777DON
CSB-BP723777DON
CSB-MP723777DON
CSB-EP723777DON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Flap endonuclease GEN-like 1 (RAD), partial CSB-YP723778OFG
CSB-EP723778OFG
CSB-BP723778OFG
CSB-MP723778OFG
CSB-EP723778OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacteroides fragilis Insertion sequence IS21-like putative ATP-binding protein (tnpB) CSB-YP723779BDQ
CSB-EP723779BDQ
CSB-BP723779BDQ
CSB-MP723779BDQ
CSB-EP723779BDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacteroides fragilis DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP723780BDQ
CSB-EP723780BDQ
CSB-BP723780BDQ
CSB-MP723780BDQ
CSB-EP723780BDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacteroides fragilis 50S ribosomal protein L4 (rplD) CSB-YP723781BDQ
CSB-EP723781BDQ
CSB-BP723781BDQ
CSB-MP723781BDQ
CSB-EP723781BDQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>